Grace Therapeutics (L8S.F) Q1 2025 Earnings

Feb 13Confirmed
Q3 2024
Q4 2024
Q1 2025
-0.36
-0.31
-0.27
-0.22

Details

Expected EPS
-0.335
Actual EPS
-0.36
Surprise EPS
-0.02
Surprise Percent
-7.46%

Description

⁨Grace Therapeutics⁩ (⁦L8S.F⁩) has reported earnings of ⁦-0.36⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts